Navigation Links
Dr. James Douglas Adds Human Growth Hormone (HGH) Therapy to IVF Protocols for Poor Responding Patients
Date:12/18/2012

Plano, Texas (PRWEB) December 18, 2012

As a reproductive endocrinologist, Dr. James Douglas specializes in helping infertile women have children. In some cases, patients do not respond well to fertility treatments, and may mistakenly believe that donor eggs are the only option. To help couples explore alternative therapies before moving to donor eggs, Dr. Douglas has begun utilizing human growth hormone (HGH) to give these patients additional choices.

“I understand the strong desire for a biological child,” explained Dr. Douglas. “We have seen success with HGH therapy in certain cases, and are now recommending it as a course of treatment for some of our poor responding patients.”

Typically, "poor responders" are patients that require increased dosing of gonadotropin therapy, have poor ovarian reserve testing and are over 35. Fertility specialists routinely see this type patients in their offices.

“Often, these women have tried in-vitro fertilization (IVF), and the cycles then failed to result in pregnancy, or were cancelled due to lack of response to medication,” Dr. Douglas said.

The benefits of HGH treatment coupled with ovarian stimulation were first reported 20 years ago. However, this treatment never gained widespread use despite studies touting the benefits.

“More studies are becoming available to support HGH therapy, and the fertility community is responding accordingly,” said Dr. Douglas.

With HGH therapy, patients take subcutaneous injections for six days during the stimulation stage of the IVF cycle. The HGH is thought to help with oocyte maturation, improving egg quality especially in older women.

HGH is also being studied for use in treatment of other medical conditions, such as multiple sclerosis, fibromyalgia, Crohn's disease and ulcerative colitis.

While cautiously optimistic, Dr Douglas sees HGH as a potential second chance for a biological child for some couples struggling with infertility

“We are excited to have another option that may allow our patients to have the babies they so desperately desire,” Dr. Douglas said.

About IVF Plano
For over 20 years, Dr. James Douglas and the team at IVF Plano fertility clinic have served the Dallas area, offering advanced diagnostic tools, the latest treatments for infertility and exceptional pregnancy rates. Dr. Douglas has helped thousands of patients in the Plano TX area achieve their goals of starting or expanding their families. For more information about the clinic, please visit http://www.ivfplano.com

Read the full story at http://www.prweb.com/releases/ivfplano/12/prweb10228871.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. James bond: A graphene/nanotube hybrid
2. Laureate Biopharma Names James D. Utterback to Board of Directors
3. Herbal Microscopy Book Receives American Botanical Councils James A. Duke Book Award
4. InspireMD Appoints Dr. James Barry to Its Board of Directors
5. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
6. Aviir, Inc.s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Womens Expo
7. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
8. Major Diabetes Peer-Review Journal Publishes Postive Results Of Ultradian Diagnostics Human Pilot Study
9. Remixed brain waves reveal soundtrack of the human brain
10. Harvards Wyss Institute models a human disease in an organ-on-a-chip
11. Antibiotic contamination a threat to humans and the environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Island, NY (PRWEB) , ... January 19, 2017 , ... ... at an exponential rate. The tremendous growth is accounted to two main factors. ... the table and the expanding network of vendors supplying FireflySci products all around the ...
(Date:1/19/2017)... Jan. 18, 2017 BD (Becton, Dickinson and Company) (NYSE: ... that it will host a live webcast of its Annual Meeting ... The webcast can be accessed from the BD ... through Tuesday, January 31, 2017. ... About BD BD is a global medical ...
(Date:1/18/2017)... 2017   Parent Project Muscular Dystrophy (PPMD) , ... Duchenne muscular dystrophy (Duchenne) , today announced a $600,000 ... of Technology (NJIT) and Talem Technologies (Talem) as part ... to assist people living with Duchenne. PPMD is ... an embedded computer, software, a force sensor and a ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... announced that it has submitted a 510(k) to the FDA, requesting clearance of ... patent-pending functional electrical stimulation (FES) technology. , The submission marks a major ...
Breaking Biology Technology:
(Date:12/16/2016)... Dec. 16, 2016   IdentyTechSolutions America LLC ... products and solutions and a cutting-edge manufacturer of ... it is offering seamless, integrated solutions that comprise ... products. The solutions provide IdentyTech,s customers with combined ... facilities from crime and theft. "We ...
(Date:12/16/2016)... NEW YORK , Dec. 16, 2016 The global ... reach USD 12.14 billion by 2021 from USD 5.31 billion in ... ... market is mainly driven by technological advancements in medical devices, launch ... devices, rising preference for wireless connectivity among healthcare providers, and increasing ...
(Date:12/15/2016)... Dec. 15, 2016   WaferGen Bio-systems, Inc. ... technology company, announced today that on December 13, 2016, ... of The Nasdaq Stock Market LLC which acknowledged that, ... of WaferGen,s common stock had been at $1.00 or ... regained compliance with Listing Rule 5550(a)(2) of the Nasdaq ...
Breaking Biology News(10 mins):